News on Enzyme Center from BioPortfolio.com http://www.BioPortfolio.com Consolidated Enzyme Center news from BioPortfolio.com Wed, 10 Feb 2010 07:58:27 GMT en Enzyme Research: Research from Ranbaxy Research Laboratories in the area of enzyme research publishedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039749&HITNO=0&MSIZE=137&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzyme%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039749&THISHREF=http://c.moreover.com/click/here.pl%3fz2538357664%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039749&HITNO=0&MSIZE=137&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzyme%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039749&THISHREF=http://c.moreover.com/click/here.pl%3fz2538357664%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: Asperfuranone from Aspergillus nidulans Inhibits Proliferation of Human Non-Small Cell Lung Cancer A549 Cells via Blocking Cell Cycle Progression and Inducing Apoptosishttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040131&HITNO=1&MSIZE=137&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzyme%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040131&THISHREF=http://c.moreover.com/click/here.pl%3fz2538602297%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040131&HITNO=1&MSIZE=137&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzyme%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040131&THISHREF=http://c.moreover.com/click/here.pl%3fz2538602297%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBasic and Clinical Pharmacology and Toxicology: EnviroLogix and the Danforth Plant Science Center Partner to Improve Nutrition in Staple Cropshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036616&HITNO=2&MSIZE=137&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzyme%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036616&THISHREF=http://c.moreover.com/click/here.pl%3fz2536685515%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036616&HITNO=2&MSIZE=137&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzyme%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036616&THISHREF=http://c.moreover.com/click/here.pl%3fz2536685515%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Enzyme Research: Research conducted at Pfizer Inc. has provided new information about enzyme researchhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033257&HITNO=3&MSIZE=137&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzyme%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033257&THISHREF=http://c.moreover.com/click/here.pl%3fz2535088530%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033257&HITNO=3&MSIZE=137&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzyme%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033257&THISHREF=http://c.moreover.com/click/here.pl%3fz2535088530%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: HIV Key Enzyme Structure Is Determinedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032493&HITNO=4&MSIZE=137&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzyme%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032493&THISHREF=http://c.moreover.com/click/here.pl%3fz2534676619%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032493&HITNO=4&MSIZE=137&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzyme%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032493&THISHREF=http://c.moreover.com/click/here.pl%3fz2534676619%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPost Chronicle: Some blood pressure medicines may cut dementia riskhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030002&HITNO=5&MSIZE=137&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzyme%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030002&THISHREF=http://c.moreover.com/click/here.pl%3fz2533375401%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030002&HITNO=5&MSIZE=137&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzyme%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030002&THISHREF=http://c.moreover.com/click/here.pl%3fz2533375401%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAlbion News Sun: Enzyme could serve as drug target against diabeteshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029468&HITNO=6&MSIZE=137&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzyme%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029468&THISHREF=http://c.moreover.com/click/here.pl%3fz2533152317%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029468&HITNO=6&MSIZE=137&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzyme%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029468&THISHREF=http://c.moreover.com/click/here.pl%3fz2533152317%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: Enzyme Research: Research reports from Gekkeikan Sake Co. Ltd. provide new insights into enzyme researchhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026505&HITNO=7&MSIZE=137&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzyme%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026505&THISHREF=http://c.moreover.com/click/here.pl%3fz2530924283%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026505&HITNO=7&MSIZE=137&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzyme%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026505&THISHREF=http://c.moreover.com/click/here.pl%3fz2530924283%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: Protalix Announces Presentation of Phase III Taliglucerase Alfa Data at WORLD Lysosomal Disease Networkhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4025436&HITNO=8&MSIZE=137&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzyme%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4025436&THISHREF=http://c.moreover.com/click/here.pl%3fz2529767524%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4025436&HITNO=8&MSIZE=137&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzyme%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4025436&THISHREF=http://c.moreover.com/click/here.pl%3fz2529767524%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Biomarin To Buy LEAD For $97M, Gives 2010 Outlookhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024892&HITNO=9&MSIZE=137&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzyme%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024892&THISHREF=http://c.moreover.com/click/here.pl%3fz2529257399%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024892&HITNO=9&MSIZE=137&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzyme%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024892&THISHREF=http://c.moreover.com/click/here.pl%3fz2529257399%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Doxycycline-Mediated Inhibition of Matrix Metalloproteinases Improves Healing After Rotator Cuff Repairhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024616&HITNO=10&MSIZE=137&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzyme%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024616&THISHREF=http://c.moreover.com/click/here.pl%3fz2529008335%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024616&HITNO=10&MSIZE=137&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzyme%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024616&THISHREF=http://c.moreover.com/click/here.pl%3fz2529008335%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAmerican Journal of Sports Medicine: Protalix Announces Presentation of Phase III Taliglucerase Alfa Data at WORLD Lysosomal Disease Networkhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018042&HITNO=11&MSIZE=137&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzyme%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018042&THISHREF=http://c.moreover.com/click/here.pl%3fz2525446533%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018042&HITNO=11&MSIZE=137&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzyme%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018042&THISHREF=http://c.moreover.com/click/here.pl%3fz2525446533%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Protalix Announces Presentation Of Phase III Taliglucerase Alfa Data At WORLD Lysosomal Disease Networkhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4021447&HITNO=12&MSIZE=137&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzyme%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4021447&THISHREF=http://c.moreover.com/click/here.pl%3fz2527230794%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4021447&HITNO=12&MSIZE=137&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzyme%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4021447&THISHREF=http://c.moreover.com/click/here.pl%3fz2527230794%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: BioMarin to Buy Lead for $97 Millionhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4023872&HITNO=13&MSIZE=137&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzyme%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4023872&THISHREF=http://c.moreover.com/click/here.pl%3fz2528449365%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4023872&HITNO=13&MSIZE=137&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzyme%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4023872&THISHREF=http://c.moreover.com/click/here.pl%3fz2528449365%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFDA News: BioMarin to buy LEAD for $97M, gives 2010 outlookhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4021006&HITNO=14&MSIZE=137&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzyme%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4021006&THISHREF=http://c.moreover.com/click/here.pl%3fz2527087780%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4021006&HITNO=14&MSIZE=137&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzyme%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4021006&THISHREF=http://c.moreover.com/click/here.pl%3fz2527087780%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comResearch & Development: